我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

高血压病亚临床靶器官损害的评估对心血管危险分层的影响(PDF)

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2011年第4期
页码:
496
栏目:
临床研究
出版日期:
2011-08-25

文章信息/Info

Title:
Effects of subclinical target organ damage evaluation on total cardiovascular risk stratification in patients with hypertension
作者:
周永兰; 任淑红; 骆秉铨; 王岚英; 曹邦明; 李岩松
徐州市中心医院北院高血压科，江苏 徐州 221005
Author(s):
ZHOU Yong-lan;  REN Shu-hong;  LUO Bing-quan;  WANG Lan-ying;  CAO Bang-ming;  LI Yang-song
Department of Hypertension, Central Hospital (North), Xuzhou 221005, Jiangsu, China
关键词:
高血压; 原发性; 亚临床靶器官损害; 总体心血管危险分层
Keywords:
hypertension;  subclinical organ damage;  total cardiovascular risk stratification
分类号:
R544.1
DOI:
61-1268/R.20110503.1533.019
文献标识码:
A
摘要:
目的:探讨除了血压水平危险分层外，不同亚临床靶器官损害的检测评估对高血压病患者心血管危险分层的影响。方法： 258例住院高血压病患者，除了常规检测项目外，还进行心脏彩超及颈动脉内中膜层厚度的测量，依据2005年中国高血压防治指南，对血压水平及添加亚临床靶器官损害评估后的高血压病患者进行危险分层。结果： 高血压病患者根据血压水平危险分层。低危 60例（23.2%）；中危115例（44.6%）；高危83例（32.2%）。这些低中危的患者通过亚临床靶器官损害评估后再行危险分层，其高危组患者所占比率明显升高，为219例（84.9%），相比较血压水平危险分层具有明显的统计学差异（P<0.01）。结论： 亚临床靶器官损害的检测评估可提高高血压病高危患者的检出率。
Abstract:
AIM:To assess the effect of evaluation of different forms of subclinical organ damage (SOD), in addition to the level of blood pressure, on total cardiovascular risk stratification in patients with hypertension. METHODS: Totally, 258 hypertensive patients underwent laboratory examinations, and their left ventricular and cartid artery structure were measured. The patients were divided into risk categories according to Hypertension Prevention Guide 2005 China before and after SOD evaluation. RESULTS: By the level of blood pressure, the patients were classified as: 23.2% with low cardiovascular risk, 44.6% with moderate cardiovascular risk, and 32.2% with high cardiovascular risk. The proportion of patients with low or moderate cardiovascular risk were reclassified by SOD evaluation: the proportion of patients with high risk was 84.9%（χ2 P<0.01）. CONCLUSION: Evaluation of different forms of SOD may significantly change the total cardiovascular risk stratification in patients with hypertension.

参考文献/References

[1]Mancia G,Laurent S,Agabiti-Rosei E,et alReappraisal of European guidelines on hypertension management:a European Society of Hypertension Task Force document[J].J Hypertens,2009,27(11):2121-2158.
[2]Sehestedt T,Jeppesen J,Hansen TW,et al.Risk stratification with the risk chart from the European Society of Hypertension compared with SCORE in the general population[J].J Hypertens,2009,27(12):2351-2357.
[3]Sehestedt T,Jeppesen J,Hansen TW,et al.Risk prediction is improved by adding markers of subclinical organ damage to SCORE[J].Eur Heart J,2010, 31(7):883-891.
[4]Waeber B,de la Sierra A,Ruilope LM.Target organ damage: how to detect it and how to treat it?[J].J Hypertens Suppl,2009,27(3):S13-S18.
[5]Agabiti-Rosei E, Muiesan ML,Salvetti M.Evaluation of subclinical target organ damage for risk assessment and treatment in the hypertensive patients: left ventricular hypertrophy[J].J Am Soc Nephrol,2006,17(4 Suppl 2):S104-S108.
[6]Zanchetti A,Hennig M,Hollweck R,et al.Baseline values but not treatment-induced changes in carotid intima-media thickness predict incident cardiovascular events in treated hypertensive patients: findings in the european lacidipine study on atherosclerosis (ELSA)[J].Circulation,2009,120(12):1084-1090.
[7]Hitha B,Pappachan JM,Pillai HB,et al.Microalbuminuria in patients with essential hypertension and its relationship to target organ damage:an Indian experience[J].Saudi J Kidney Dis Transpl,2008,19(3):411-419.

备注/Memo

备注/Memo:
收稿日期：2010-11-11.作者简介：周永兰，副主任医师，硕士Email:zhouyonglan941001@163.com
更新日期/Last Update: 2011-06-02